Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Agenus
AddedFeb 19, 2024
UpdatedJun 18, 2026
Agenus

Agenus

Public

Agenus Inc., a global biotech firm, develops and manufactures immuno-oncology products for enhanced patient care.

HQ
Lexington, MA, US
Founded
1994
Overview
Compare
Fundraising
Employees
Website

Agenus Inc. is a biotechnology company focused on developing immuno-oncology products to combat cancer. Founded in 1994 by Garo H. Armen and Pramod K. Srivasta, the company specializes in harnessing the power of the immune system to create therapies with curative intent for cancer patients. Agenus' product portfolio includes checkpoint antibodies and other synergistic agents designed to enhance patient outcomes.

As a public company traded on NASDAQ under the ticker AGEN, Agenus has made significant strides in the field of immunotherapy. Their next-generation CTLA-4 antibody, botensilimab, represents a key innovation in their pipeline. The company's global presence and commitment to advancing cancer treatment have positioned Agenus as a notable player in the biotechnology industry.

Agenus - Similar Companies

Seagen logo

Seagen

seagen.com

argenx logo

argenx

MacroGenics logo

MacroGenics

macrogenics.com

Clovis Oncology logo

Clovis Oncology

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

INmune Bio logo

INmune Bio

inmunebio.com

ImmunityBio logo

ImmunityBio

immunitybio.com

BeOne Medicines logo

BeOne Medicines

beigene.com

Iovance Biotherapeutics logo

Iovance Biotherapeutics

iovance.com

Mersana Therapeutics logo

Mersana Therapeutics

mersana.com

NextCure logo

NextCure

nextcure.com

AIM Immunotech logo

AIM Immunotech

aimimmuno.com

Nantkwest logo

Nantkwest

Immune-Onc Therapeutics logo

Immune-Onc Therapeutics

immuneonc.com

Imunon logo

Imunon

imunon.com

Agenus - Quick Facts

Who are Agenus' competitors?

Companies similar to Agenus include Seagen, argenx, MacroGenics and Clovis Oncology.

When was Agenus founded?

Agenus was founded in 1994.

Where is Agenus' headquarters located?

Agenus' headquarters is located in Lexington, MA, US.

When was Agenus' last funding round?

Agenus' most recent funding round was for $40M (USD) in October 2018.

How much has Agenus raised to-date?

As of Oct 11, 2018, Agenus has raised a total of $271.1M (USD).

How many employees does Agenus have?

Agenus has 533 employees as of Feb 6, 2024.

Agenus - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Immuno-Oncology Products
Tags
  • Healthtech
Unique IDs
  • ein: 061562417
  • secCik: 0001098972
  • ticker: AGEN
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research